for more on this, let's speak to kelly baden, vice president of public policy at the guttmacher institutes hearin: today onwards? sure. today the court is hearing a — today onwards? sure. today the court is hearing a case _ today onwards? sure. today the court is hearing a case that _ today onwards? sure. today the court is hearing a case that aims _ today onwards? sure. today the court is hearing a case that aims to - is hearing a case that aims to restrict the access of mifepristone one of two bill is primarily used in medication abortion in the us. this drug has more than 20 years of real—life safety use and evidence in the united states, its been approved by the fda since 2000 here and an even longer track record globally that speaks to its safety and efficacy, and the court with this case could make some decisions to essentially further restrict access to the drug, regardless of where you live. 50 to the drug, regardless of where you live. �* , to the drug, regardless of where you live, �*, ., to the drug, regardless of where you live. �*, ., ., x live. so it's about what the fda did